Cardiff Oncology, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cardiff Oncology, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2012 to Q3 2024.
  • Cardiff Oncology, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 4, 2024 was 51.1M shares, a 14.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 51.1M +6.46M +14.5% Nov 4, 2024 10-Q 2024-11-07
Q2 2024 46.5M +1.87M +4.19% Aug 6, 2024 10-Q 2024-08-08
Q1 2024 44.7M +47.4K +0.11% Apr 25, 2024 10-Q 2024-05-02
Q3 2023 44.7M 0 0% Oct 26, 2023 10-Q 2023-11-02
Q2 2023 44.7M +1.34M +3.1% Aug 3, 2023 10-Q 2023-08-09
Q1 2023 44.7M +1.37M +3.17% Apr 27, 2023 10-Q 2023-05-04
Q3 2022 44.7M +5.13M +13% Oct 27, 2022 10-Q 2022-11-03
Q2 2022 43.3M +3.78M +9.56% Jul 28, 2022 10-Q 2022-08-04
Q1 2022 43.3M +5.75M +15.3% Apr 28, 2022 10-Q 2022-05-05
Q3 2021 39.6M +4.23M +12% Oct 29, 2021 10-Q 2021-11-04
Q2 2021 39.6M +16.3M +70.3% Jul 30, 2021 10-Q 2021-08-05
Q1 2021 37.6M +25.2M +205% Apr 29, 2021 10-Q 2021-05-06
Q3 2020 35.3M +27.6M +356% Oct 30, 2020 10-Q 2020-11-05
Q2 2020 23.2M +17.8M +327% Aug 6, 2020 10-Q 2020-08-11
Q1 2020 12.3M +7.06M +135% Apr 30, 2020 10-Q 2020-05-07
Q3 2019 7.74M -15.2M -66.3% Oct 31, 2019 10-Q 2019-11-07
Q2 2019 5.45M -12.2M -69.2% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 5.25M -54.1M -91.2% Apr 30, 2019 10-Q 2019-05-07
Q3 2018 23M -15.1M -39.7% Oct 31, 2018 10-Q 2018-11-07
Q2 2018 17.7M -19.6M -52.5% Jul 31, 2018 10-Q 2018-08-03
Q1 2018 59.4M +28.4M +91.7% Apr 30, 2018 10-Q 2018-05-08
Q4 2017 55.3M Feb 12, 2018 10-K 2018-02-26
Q3 2017 38.1M +7.49M +24.5% Oct 31, 2017 10-Q 2017-11-09
Q2 2017 37.3M +7.12M +23.6% Jul 31, 2017 10-Q 2017-08-09
Q1 2017 31M +1.11M +3.72% Apr 28, 2017 10-Q 2017-05-10
Q3 2016 30.6M +893K +3% Oct 31, 2016 10-Q 2016-11-09
Q2 2016 30.1M +525K +1.77% Jul 31, 2016 10-Q 2016-08-04
Q1 2016 29.9M +5.41M +22.1% Apr 29, 2016 10-Q 2016-05-10
Q3 2015 29.7M +10.8M +57.2% Oct 30, 2015 10-Q 2015-11-09
Q2 2015 29.6M +10.7M +56.7% Jul 31, 2015 10-Q 2015-08-10
Q1 2015 24.5M +5.55M +29.4% Apr 30, 2015 10-Q 2015-05-05
Q3 2014 18.9M -208 0% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 18.9M +56.5K +0.3% Aug 5, 2014 10-Q 2014-08-07
Q1 2014 18.9M +3.3M +21.1% Mar 13, 2014 10-K 2014-03-17
Q3 2013 18.9M +4.72M +33.3% Nov 8, 2013 10-Q 2013-11-14
Q2 2013 18.8M +4.67M +32.9% Aug 9, 2013 10-Q 2013-08-14
Q1 2013 15.6M -53.6M -77.4% Mar 22, 2013 10-K 2013-04-01
Q3 2012 14.2M Nov 9, 2012 10-Q 2012-11-14
Q2 2012 14.2M Aug 9, 2012 10-Q 2012-08-14
Q1 2012 69.2M May 14, 2012 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.